Elie Hassenfeld on GiveWell

Episode Summary

Executive Summary: Russ Roberts interviews Ellie Hassenfeld about GiveWell’s origins, mission, and method. The conversation centers on how GiveWell uses transparent, evidence-based analysis to identify a small number of charities—mostly in global health—that appear to save or improve lives at very low cost, while openly acknowledging uncertainty, tradeoffs, and the limits of quantification.

Main Topics: Origins of GiveWell (Priority: 5/5): Hassenfeld explains that GiveWell began when he and Holden Karnofsky, frustrated by the lack of useful charity effectiveness information, set out to evaluate where donations could do the most good. Top charity selection and evidence standards (Priority: 5/5): GiveWell’s current top charities include malaria prevention, vitamin A supplementation, and immunization incentives; selection is based on randomized evidence, expected impact per dollar, and room for more funding. Quantification, uncertainty, and fungibility (Priority: 5/5): The discussion emphasizes that GiveWell models impact per dollar but adjusts for implementation gaps, changing conditions, insecticide resistance, and the possibility that its funds displace other donors. Moral philosophy and effective altruism (Priority: 4/5): Roberts and Hassenfeld discuss utilitarian reasoning, the tension between saving lives and broader quality-of-life concerns, and the role of donor values beyond maximization. Learning from mistakes and program scaling (Priority: 4/5): Hassenfeld describes past errors, including over-relying on reported data and underestimating the difficulty of scaling promising interventions, leading GiveWell to value long-term learning and track record. Transparency and public critique (Priority: 4/5): GiveWell’s public research, the Change Our Mind contest, and efforts to improve legibility show its commitment to being scrutinizable and to refining its methods over time. Crowding in vs. crowding out (Priority: 3/5): The conversation notes that GiveWell’s endorsements can both displace other donations and attract new funding, while also helping programs gain credibility with larger institutional funders.

Key Arguments: GiveWell emerged because its founders could not find trustworthy, actionable information on charity effectiveness and wanted a donor-facing research resource. The organization prioritizes programs with strong evidence, especially randomized controlled trials, and seeks interventions with high expected impact per dollar. GiveWell’s top charities are not chosen solely by formulas; human judgment, organizational track record, transparency, and unmodeled upside matter when estimates are close. The best charitable opportunities GiveWell finds are largely in low-income countries because the marginal benefits of health interventions are often much larger there than in richer places. Saving lives in childhood is not just about adding years; many children who survive go on to live long and relatively happy lives, though poverty and suffering remain serious. GiveWell is more comfortable funding interventions whose effects can be observed and learned from over time than speculative macro-level anti-poverty strategies. Quantitative estimates are useful but deeply uncertain, so the organization deliberately builds in humility and revises judgments when evidence or implementation realities change. Public transparency is central: by publishing research and inviting critique, GiveWell both disciplines itself and helps outsiders understand the reasoning behind its recommendations. A charity recommendation can cause both crowding out and crowding in; GiveWell tries to account for both effects when estimating real-world impact. Donors need not adopt full utilitarianism; Hassenfeld argues that people can separate personal/family/community giving from a separate bucket aimed at maximal global impact.

Data Points: Year GiveWell started: 2007 - Hassenfeld and Holden Karnofsky founded GiveWell after a year of part-time work. Date of episode: September 7, 2023 - Recorded introduction to the EconTalk interview. Years GiveWell has been around: 15 years - Hassenfeld describes the organization’s operating history. Donors using GiveWell recommendations: more than 100,000 - Cumulative donor count over GiveWell’s history. Funds directed via recommendations: more than $1 billion - Cumulative amount donated to GiveWell-recommended charities. Top charities mentioned: 4 - Two malaria programs, vitamin A supplementation, and New Incentives. Malaria-related top charities: 2 - Malaria Consortium’s SMC and Against Malaria Foundation’s net program. Vitamin A supplementation mortality reduction: about 25% - Hassenfeld says supplementation significantly reduces child mortality in deficient populations. Estimated cost per life saved: about $5,000 - Rough benchmark across GiveWell’s top programs. Funding threshold: 10x direct cash transfers - Programs must exceed GiveWell’s benchmark relative to giving cash directly. Program funding scale: approximately $500 million per year - Current annual amount GiveWell is raising and allocating. Minimum support before top-charity status: at least $10 million for at least a year - GiveWell wants significant prior funding experience before elevating an organization. Change Our Mind prize: $20,000 - Top prize in the public critique contest. High-quality contest submissions: more than 50 - GiveWell received many serious critiques from outsiders. Internal size: 70 people - GiveWell’s approximate staff size, about half in research. Typical crowding-out estimate example: median 40 cents displaced per $1 given - Used to illustrate uncertainty around fungibility adjustments. Possible crowding-out range example: 10 cents to 80 cents - Illustrative confidence interval for displacement effect. No Lean Season scale example: 1,000 to 2,000 people - Small-scale trial participants in Bangladesh before rollout problems at scale.

Pivotal Quotes: "We were really surprised that we couldn't find useful information that would help guide our decisions." — Ellie Hassenfeld: Explaining why he and Holden Karnofsky started GiveWell. "We don't care what give well donors' money, the sort of literal dollars that we direct accomplish. We care about, ideally, the causal impact that our work has on the world." — Ellie Hassenfeld: Describing GiveWell’s approach to fungibility and real-world impact. "We're very transparent. If you want to spend a lot of time, I mean, hundreds of hours, you can get the answer to the questions you have about our work." — Ellie Hassenfeld: Discussing public research and the challenge of making the analysis legible.

Implications: The interview presents GiveWell as a model for transparent, evidence-driven philanthropy, while showing that good charitable allocation still requires judgment, humility, and willingness to revise beliefs as evidence and implementation realities change.